ESR1 and neoplasm: But patients with a tumor size > 2 cm, lymph node positive, grade III, clinical stage II + III, or HER2 positive had significantly shorter survival times, whereas being ER or HR positivity remarkably improved the survival of EBC patients (log-rank P < 0.05, Table 1).